Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease whose predominant neuropathological signature is the selective loss of medium spiny neurons in the striatum. Despite this selective neuropathology, the mutant protein (huntingtin) is found in virtually every cell so fa...
Saved in:
Main Authors: | Sydney R Coffey, Robert M Bragg, Shawn Minnig, Seth A Ament, Jeffrey P Cantle, Anne Glickenhaus, Daniel Shelnut, José M Carrillo, Dominic D Shuttleworth, Julie-Anne Rodier, Kimihiro Noguchi, C Frank Bennett, Nathan D Price, Holly B Kordasiewicz, Jeffrey B Carroll |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175968&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The N17 domain of huntingtin as a multifaceted player in Huntington’s disease
by: Hyunju Cho
Published: (2025-01-01) -
Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease
by: Hui Xu, et al.
Published: (2025-02-01) -
Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease
by: Mahdi Bagherpoor Helabad, et al.
Published: (2024-12-01) -
The Role of the Immune System in Huntington’s Disease
by: Gisa Ellrichmann, et al.
Published: (2013-01-01) -
The Role of Dopamine and Glutamate Modulation in Huntington Disease
by: Sumeer K. Mittal, et al.
Published: (2013-01-01)